Abdulrahman M Alahdal1, Ahmed A Elberry. 1. Department of Clinical Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Abstract
OBJECTIVE: To determine whether appropriate dose adjustment was taken into account or not by the physicians when prescribing drugs in patients with renal impairment. DESIGN: A retrospective chart review was performed and included 98 adult in-patients, diagnosed with renal impairment based on clinical evaluation and laboratory data, in King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia, who was admitted to the hospital from September 2005 to January 2011. Data of the patients were noted and recorded including baseline demographics, clinical data, laboratory data, renal state, treatment data and medications. RESULTS: The initial number of the patients was reduced to 80 where a total of 502 drugs were investigated in the present study with an average of six drugs per patient. Of these 502 studied drugs, 196 (39%) required dose adjustment where 92 (46.9%) were adjusted and 104 (53.1%) were not adjusted. It was found also that most of the drugs requiring dose adjustment were antibiotics (39.8%). CONCLUSION: The current study confirms that physicians still do not take into account sufficiently patients' renal function when prescribing drugs. Continuous medical education and collaboration with clinical pharmacist should be encouraged for quality improvement in patients with renal impairment.
OBJECTIVE: To determine whether appropriate dose adjustment was taken into account or not by the physicians when prescribing drugs in patients with renal impairment. DESIGN: A retrospective chart review was performed and included 98 adult in-patients, diagnosed with renal impairment based on clinical evaluation and laboratory data, in King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia, who was admitted to the hospital from September 2005 to January 2011. Data of the patients were noted and recorded including baseline demographics, clinical data, laboratory data, renal state, treatment data and medications. RESULTS: The initial number of the patients was reduced to 80 where a total of 502 drugs were investigated in the present study with an average of six drugs per patient. Of these 502 studied drugs, 196 (39%) required dose adjustment where 92 (46.9%) were adjusted and 104 (53.1%) were not adjusted. It was found also that most of the drugs requiring dose adjustment were antibiotics (39.8%). CONCLUSION: The current study confirms that physicians still do not take into account sufficiently patients' renal function when prescribing drugs. Continuous medical education and collaboration with clinical pharmacist should be encouraged for quality improvement in patients with renal impairment.
Authors: L Salomon; G Deray; M C Jaudon; C Chebassier; P Bossi; V Launay-Vacher; B Diquet; J M Ceza; S Levu; G Brücker; P Ravaud Journal: Int J Qual Health Care Date: 2003-08 Impact factor: 2.038